Ledent RX SRL
Ledent RX reported total assets of 996,217 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Ledent RX shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +41 % Total assets +53 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ledent RX's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 204,397 € | ||||
| Equity | 611,118 € | ||||
| Cash | 747,014 € | ||||
| EBITDA | 314,356 € | ||||
| Total assets | 996,217 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 29 Sep 2022
Ledent RX's financial analysis
- Solvency61.3%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ledent RX
Ledent RX's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0860.727.817
- VAT number
- BE0860727817
- Peppol
- Registered · 0208:0860727817 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2003
- Registered office
- 6900 Marche-en-Famenne
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Ledent RX (SRL) has been based in Marche-en-Famenne since 2003, active in: medical specialists activities. For 2025, it reports a net profit of 204,397 € and equity of 611,118 €; its revenue is not published. Its solvency stands at 61.3%, below the median of its sector (65.0%).
Companies similar to Ledent RX
Companies in the same business, of comparable size and area, outside its group.
- Blairon-Bettens Medical specialists activities Braine-l'Alleud · balance sheet 996,855 €
- Docteur A.Nkeshimana Medical specialists activities Ham-sur-Heure-Nalinnes · balance sheet 995,498 €
- Dr. Sarah Van Loo Medical specialists activities Stekene · balance sheet 995,250 €
- Marievoet S Medical specialists activities Montigny-le-Tilleul · balance sheet 997,710 €
- DR.Yves Hagers Medical specialists activities Koekelare · balance sheet 997,786 €
- Jerga Medical specialists activities Aartselaar · balance sheet 997,951 €
- Dr. G.Caluwé Medical specialists activities Zandhoven · balance sheet 994,208 €
- Dr. C. E. Sommeling, Plastische Chirurgie Medical specialists activities Deinze · balance sheet 994,076 €
Frequently asked questions about Ledent RX
What is the revenue of Ledent RX?
Ledent RX files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ledent RX?
In Belgium, the VAT number is the company number prefixed with BE: BE0860727817 for Ledent RX, if the company is VAT-registered. Its company number (CBE) is 0860.727.817.
Where is the registered office of Ledent RX?
According to the CBE register, the registered office of Ledent RX is in 6900 Marche-en-Famenne.
What is the equity of Ledent RX?
At the close of the 2025 financial year, the equity of Ledent RX amounts to 611,118 €, a solvency of 61.3% of total assets.
Who manages Ledent RX?
The register lists 1 active mandates at Ledent RX. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ledent RX
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →